InhaleRx Limited is involved in the development and commercialization of medical diagnostic and monitoring technology. The company also develops technology that facilitates the management, diagnosis, and evaluation of chronic diseases and the evaluation of skin diseases.

IRX Overview Presentation - SRX-25 and Nexalis

Application for quotation of securities - IRX

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

InhaleRx (IRX AU)

IRX Overview Presentation - SRX-25 and Nexalis

Application for quotation of securities - IRX

Initial Allotment of Placement Shares

Entitlement Offer - Ineligible Shareholders Letter

Dispatch of Entitlement Offer Prospectus

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)